Cyclerion Therapeutics, Inc. Common Stock (CYCN) is a publicly traded Healthcare sector company. As of August 4, 2026, CYCN trades at $3.54 with a market cap of $15.11M and a P/E ratio of -2.64. CYCN moved +0.00% today. Year to date, CYCN is +176.38%; over the trailing twelve months it is +25.97%. Its 52-week range spans $1.03 to $8.48. Rallies surfaces CYCN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CYCN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $3.54 |
| Market Cap | $15.11M |
| P/E Ratio | -2.64 |
| EPS | $-1.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.48 |
| 52-Week Low | $1.03 |
| Volume | 5.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.99M |
| Net Income | $-5.28M |
| Gross Margin | 0.00% |
CYCN analyst coverage data. Average price target: $0.00.